DQ [DAQO NEW ENERGY] F-1/A: CALCULATION OF REGISTRATION FEE Title of each class

[CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered (1)(2) Proposed maximum Amount of Ordinary Shares, par value $0.0001 per share (3) $100,000,000 $7,130.00 (4) (1) Estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(o) under the Securities Act of 1933. (2) (3) American depositary shares issuable upon] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the use in this Amendment No. 5 to Registration Statement No. 333-164307 of our report dated August 18, 2010 relating to the consolidated financial statements and financial statement schedule of Daqo New Energy Corp., which report expresses an unqualified opinion on the consolidated financial statements and financial statement schedule and]

By | 2016-03-02T09:50:47+00:00 September 13th, 2010|Categories: Chinese Stocks, DQ, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-C: (Original Filing)

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person] [HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

By | 2016-02-29T16:37:57+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-C: SCHEDULE TO (Rule 14d-100) Tender Offer Statement under

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person] [HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

By | 2016-02-29T16:39:27+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar